Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Hoshi

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta|April 29, 2014
Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitisHirofumi Ohtaki, Hiroyasu Ito, Kazuki Ando, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 19, 2010
RET signaling is required for survival and normal function of nonpeptidergic nociceptorsJudith P Golden, Masato Hoshi, Mohammed A Nassar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouseMasato Hoshi, Kuniaki Saito, Akira Hara, et al.
The Journal of Biological Chemistry|August 16, 2011
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycinYosuke Osawa, Hiromitsu Kanamori, Ekihiro Seki, et al.
Cancer Science|June 3, 2015
Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in miceManabu Takamatsu, Akihiro Hirata, Hirofumi Ohtaki, et al.
Frontiers in Immunology|May 30, 2024
Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritisNaonobu Sugiyama, Frances E Terry, Andres H Gutierrez, et al.
Cancer Science|February 11, 2012
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenaseKengo Ogawa, Takeshi Hara, Masahito Shimizu, et al.
International Journal of Rheumatic Diseases|July 15, 2025
Incidence and Risk of Malignancy in Japanese Patients With Rheumatoid Arthritis in the National Database of Rheumatic Diseases in Japan (NinJa Database)Toshihiro Matsui, Aosa Kamezaki-Nakagawa, Masato Hoshi, et al.
Journal of Gastroenterology and Hepatology|June 23, 2022
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE OpenKatsuyoshi Matsuoka, Tadakazu Hisamatsu, Hyo Jong Kim, et al.
European Journal of Haematology|December 10, 2009
Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOPTakeshi Yoshikawa, Takeshi Hara, Hisashi Tsurumi, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|April 29, 2014
Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitisHirofumi Ohtaki, Hiroyasu Ito, Kazuki Ando, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 19, 2010
RET signaling is required for survival and normal function of nonpeptidergic nociceptorsJudith P Golden, Masato Hoshi, Mohammed A Nassar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouseMasato Hoshi, Kuniaki Saito, Akira Hara, et al.
The Journal of Biological Chemistry|August 16, 2011
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycinYosuke Osawa, Hiromitsu Kanamori, Ekihiro Seki, et al.
Cancer Science|June 3, 2015
Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in miceManabu Takamatsu, Akihiro Hirata, Hirofumi Ohtaki, et al.
Frontiers in Immunology|May 30, 2024
Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritisNaonobu Sugiyama, Frances E Terry, Andres H Gutierrez, et al.
Cancer Science|February 11, 2012
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenaseKengo Ogawa, Takeshi Hara, Masahito Shimizu, et al.
International Journal of Rheumatic Diseases|July 15, 2025
Incidence and Risk of Malignancy in Japanese Patients With Rheumatoid Arthritis in the National Database of Rheumatic Diseases in Japan (NinJa Database)Toshihiro Matsui, Aosa Kamezaki-Nakagawa, Masato Hoshi, et al.
Journal of Gastroenterology and Hepatology|June 23, 2022
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE OpenKatsuyoshi Matsuoka, Tadakazu Hisamatsu, Hyo Jong Kim, et al.
European Journal of Haematology|December 10, 2009
Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOPTakeshi Yoshikawa, Takeshi Hara, Hisashi Tsurumi, et al.
Pageof 8